{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:56Z","timestamp":1787020916300,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-infectious complications have become a major cause of morbidity and mortality in patients with Common Variable Immunodeficiency (CVID). The monitoring of patients with CVID prior to the development of non-infectious complications is not well defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our objectives were to systematically review the current literature on the monitoring of CVID patients without non-infectious complications and to develop recommendations for such monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      MEDLINE and EMBASE were searched from January 1\n                      <jats:sup>st<\/jats:sup>\n                      , 2000 to March 25\n                      <jats:sup>th<\/jats:sup>\n                      , 2021. Studies on any aspects of CVID monitoring were included. Studies that included only children, on monitoring CVID patients with existing non-infectious complications, or in the format of case reports were excluded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine studies on CVID monitoring, including 3 cohort studies, 3 experts\u2019 opinions, 2 consensus statements and a single guideline report were identified. These studies revealed that clinical assessment and bloodwork were preformed every 6 to 12\u00a0months in asymptomatic patients. Some centers performed computerized tomography scan of the chest every 2\u20135\u00a0years to identify chronic lung disease, although the majority did chest imaging in accordance with clinical indications. Pulmonary function tests were done annually at most centers. Most studies did not address the role of abdominal imaging to screen for liver diseases or endoscopy to screen for gastric cancer in asymptomatic patients with uncomplicated CVID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is paucity of evidence-based information to guide the routine monitoring of CVID patients without non-infectious complications. Prospective studies are needed to determine the best monitoring practices in this group of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-022-00661-7","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T08:02:49Z","timestamp":1646812969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-2067","authenticated-orcid":false,"given":"Erika Yue","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Betschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"1","key":"661_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116-126e11.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"661_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"661_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaci.2012.03.025","volume":"129","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C, Maglione PJ. Common variable immunodeficiency. J Allergy Clin Immunol. 2012;129(5):1425-1426.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"661_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-American group for immunodeficiency) and ESID (European society for immunodeficiencies). Clin Immunol. 1999;93(3):190\u2013710.","journal-title":"Clin Immunol"},{"issue":"5","key":"661_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2014","unstructured":"Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2014;136(5):1186-1205.e78.","journal-title":"J Allergy Clin Immunol"},{"key":"661_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","volume":"5","author":"R Ameratunga","year":"2014","unstructured":"Ameratunga R, Brewerton M, Slade C, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5:415.","journal-title":"Front Immunol"},{"issue":"2","key":"661_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277\u201386.","journal-title":"Blood"},{"issue":"5","key":"661_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","volume":"130","author":"H Chapel","year":"2012","unstructured":"Chapel H, Lucas M, Patel S, Lee M, Cunningham-Rundles C, Resnick E, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012;130(5):1197-1198.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"661_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.chest.2019.05.009","volume":"156","author":"S Gupta","year":"2019","unstructured":"Gupta S, Pattanaik D, Krishnaswamy G. Common variable immune deficiency and associated complications. Chest. 2019;156(3):579\u201393.","journal-title":"Chest"},{"key":"661_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1067\/mai.2002.124999","volume":"109","author":"PJ Busse","year":"2002","unstructured":"Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109:1001\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"661_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","volume":"27","author":"I Quinti","year":"2007","unstructured":"Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308\u201316.","journal-title":"J Clin Immunol"},{"issue":"3","key":"661_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","volume":"31","author":"I Quinti","year":"2011","unstructured":"Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: Results from a multicenter prospective cohort study. J Clin Immunol. 2011;31(3):315\u201322.","journal-title":"J Clin Immunol"},{"issue":"7","key":"661_CR13","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650\u20137.","journal-title":"Blood"},{"key":"661_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","volume":"128","author":"PB Burns","year":"2011","unstructured":"Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305\u201310.","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"661_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s10875-014-0068-6","volume":"34","author":"LJ Maarschalk-Ellerbroek","year":"2014","unstructured":"Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM, Lammers JWJ, Bloem AC, Hoepelman AIM, et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol. 2014;34(6):642\u201354.","journal-title":"J Clin Immunol"},{"issue":"1","key":"661_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jaci.2016.11.050","volume":"140","author":"WJM Janssen","year":"2017","unstructured":"Janssen WJM, Mohamed Hoesein F, Van de Ven AAJM, Maarschalk J, van Royen F, de Jong PA, et al. IgG trough levels and progression of pulmonary disease in pediatric and adult common variable immunodeficiency disorder patients. J Allergy Clin Immunol. 2017;140(1):303-306.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"661_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s10875-012-9720-1","volume":"32","author":"H Abolhassani","year":"2012","unstructured":"Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol. 2012;32(6):1180\u201392.","journal-title":"J Clin Immunol"},{"issue":"2","key":"661_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cei.13012","volume":"190","author":"S Jolles","year":"2017","unstructured":"Jolles S, S\u00e1nchez-Ram\u00f3n S, Quinti I, Soler-Palac\u00edn P, Agostini C, Florkin B, et al. Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group. Clin Exp Immunol. 2017;190(2):226\u201334.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"661_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","volume":"116","author":"C Cunningham-Rundles","year":"2010","unstructured":"Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116(1):7\u201315.","journal-title":"Blood"},{"issue":"3","key":"661_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/cei.13272","volume":"196","author":"C Bethune","year":"2019","unstructured":"Bethune C, Egner W, Garcez T, Huissoon A, Jolles S, Karim Y, et al. British Society for Immunology\/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders. Clin Exp Immunol. 2019;196(3):328\u201335.","journal-title":"Clin Exp Immunol"},{"key":"661_CR21","unstructured":"Buckley R. Diagnostic & clinical care guidelines for primary immunodeficiency diseases, 3rd edn. 2015. https:\/\/primaryimmune.org\/sites\/default\/files\/publications\/2015-Diagnostic-and-Clinical-Care-Guidelines-for-PI_1.pdf"},{"key":"661_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"B Piqueras","year":"2003","unstructured":"Piqueras B, Lavenu-Bombled C, Galicier L, van der Bergeron Cruyssen F, Mouthon L, Chevret S, Debr\u00e9 P, Schmitt C, Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385\u2013400.","journal-title":"J Clin Immunol"},{"issue":"2","key":"661_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3906\/sag-1412-108","volume":"46","author":"AZ \u00c7ali\u015fkaner","year":"2016","unstructured":"\u00c7ali\u015fkaner AZ, Reisli \u0130, Arslan \u015e, U\u00e7ar R, Ataseven H, Sel\u00e7uk NY. Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish J Med Sci. 2016;46(2):430\u20136.","journal-title":"Turkish J Med Sci"},{"key":"661_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1464-410X.1982.tb06977.x","volume":"54","author":"AD Webster","year":"1982","unstructured":"Webster AD, Taylor-Robinson D, Furr PM, Asherson GL. Chronic cystitis and urethritis associated with ureaplasmal and mycoplasmal infection in primary hypogammaglobulinaemia. Br J Urol. 1982;54:287\u201391.","journal-title":"Br J Urol"},{"issue":"6","key":"661_CR25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1378\/chest.10-3147","volume":"140","author":"G Serra","year":"2011","unstructured":"Serra G, Milito C, Mitrevski M, et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest. 2011;140(6):1581\u20139.","journal-title":"Chest"},{"issue":"7","key":"661_CR26","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.jaip.2019.04.016","volume":"7","author":"V Azzu","year":"2019","unstructured":"Azzu V, Fonseca M, Duckworth A, Kennard L, Moini N, Qurashi M, et al. Liver disease is common in patients with common variable immunodeficiency and predicts mortality in the presence of cirrhosis or portal hypertension. J Allergy Clin Immunol Pract. 2019;7(7):2484-2486.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"661_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaip.2013.09.013","volume":"1","author":"M Kuruvilla","year":"2013","unstructured":"Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573\u201382.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"661_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/cei.12915","volume":"188","author":"S Jolles","year":"2017","unstructured":"Jolles S, Chapel H, Litzman J. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach. Clin Exp Immunol. 2017;188(3):333\u201341.","journal-title":"Clin Exp Immunol"},{"key":"661_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","volume":"144","author":"C Milito","year":"2019","unstructured":"Milito C, Pulvirenti F, Cinetto F, et al. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies. J Allergy Clin Immunol. 2019;144:584\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"661_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","volume":"4","author":"E Schussler","year":"2016","unstructured":"Schussler E, Beasley MB, Maglione PJ. Lung disease in primary antibody deficiencies. J Allergy Clin Immunol Pract. 2016;4(6):1039\u201352.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"661_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10875-018-0488-9","volume":"38","author":"J Akhter","year":"2018","unstructured":"Akhter J, Lefaiver CA, Scalchunes C, DiGirolamo M, Warnatz K. Immunologist\u2019s perspectives on assessment and management of lung disease in CVID: a survey of the membership of the Clinical Immunology Society and the European Society for Immunodeficiencies. J Clin Immunol. 2018;38(3):237\u201346.","journal-title":"J Clin Immunol"},{"issue":"5","key":"661_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1399-3038.2009.00963.x","volume":"21","author":"CML Touw","year":"2010","unstructured":"Touw CML, Van De Ven AA, De Jong PA, Terheggen-Lagro S, Beek E, Sanders EAM, et al. Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol. 2010;21(5):793\u2013805.","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"661_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5114\/ceji.2018.77385","volume":"43","author":"M Mahmoodi","year":"2018","unstructured":"Mahmoodi M, Abolhassani H, Mozdarani H, et al. In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency. Cent Eur J Immunol. 2018;43(2):155\u201361.","journal-title":"Cent Eur J Immunol"},{"key":"661_CR34","first-page":"1","volume":"1","author":"HE Ho","year":"2020","unstructured":"Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;1:1\u201314.","journal-title":"Front Immunol"},{"key":"661_CR35","unstructured":"Caruso M et al. Ultrasound assessment of the hepatosplenic involvement in patients with Common Variable Immunodeficiency. Scientific Exhibit. European Society of Radiology. 2019. https:\/\/epos.myesr.org\/poster\/esr\/ecr2019\/C-1545. Accessed 15 Nov 2020."},{"key":"661_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s10875-018-0546-3","volume":"38","author":"DK van der Poorten","year":"2018","unstructured":"van der Poorten DK, McLeod D, Ahlenstiel G, et al. Gastric cancer screening in common variable immunodeficiency. J Clin Immunol. 2018;38:768\u201377.","journal-title":"J Clin Immunol"},{"key":"661_CR37","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3389\/fimmu.2018.02546","volume":"9","author":"F Pulvirenti","year":"2018","unstructured":"Pulvirenti F, Pecoraro A, Cinetto F, et al. Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency. Front Immunol. 2018;9:2546.","journal-title":"Front Immunol"},{"key":"661_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","volume":"42","author":"B Pillay","year":"2016","unstructured":"Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56\u201372.","journal-title":"Cancer Treat Rev"},{"key":"661_CR39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/imj.13965","volume":"48","author":"M Ferman","year":"2018","unstructured":"Ferman M, Lim AH, Hossain M, Siow GW, Andrews JM. Multidisciplinary team meetings appear to be effective in inflammatory bowel disease management: an audit of process and outcomes. Intern Med J. 2018;48:1102\u20138.","journal-title":"Intern Med J"},{"issue":"3","key":"661_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.18176\/jiaci.0485","volume":"30","author":"Y Barrios","year":"2020","unstructured":"Barrios Y, Franco A, Alonso-Larruga A, et al. Multidisciplinary team work to succeed: a primary immunodeficiency unit experience. J Investig Allergol Clin Immunol. 2020;30(3):208\u201310. https:\/\/doi.org\/10.18176\/jiaci.0485.","journal-title":"J Investig Allergol Clin Immunol."},{"issue":"5","key":"661_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s10875-017-0401-y","volume":"37","author":"N Mahlaoui","year":"2017","unstructured":"Mahlaoui N, Warnatz K, Jones A, Workman S, Cant A. Advances in the care of primary immunodeficiencies (PIDs): from birth to adulthood. J Clin Immunol. 2017;37(5):452\u201360.","journal-title":"J Clin Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-022-00661-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T08:07:23Z","timestamp":1646813243000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-022-00661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1186\/s13223-022-00661-7","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to participate"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}